Valuation (7%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.16 | N/A |
| PEG Ratio (TTM) | 0.00 | N/A |
| P/S Ratio (TTM) | 2.90 | N/A |
| P/B Ratio (TTM) | -0.31 | N/A |
| P/FCF Ratio (TTM) | -0.46 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.08 | N/A |
| Price to 5YR AVG FCF Ratio | -0.49 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -78.54% | N/A |
| ROE (TTM) | 870.27% | N/A |
| Net Profit Margin (TTM) | -1,735.21% | N/A |
| ROIC 5YR AVG | -146.44% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -15.36% | -57.58% | -42.73% |
| Revenue | 4,327.94% | 214.99% | 150.93% |
| Net Income | -25.95% | -85.38% | -69.03% |
| Cash Flow | 11.42% | -84.32% | -46.22% |
Health (7%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.74 | N/A |
| Quick Ratio (TTM) | 0.44 | N/A |
| D/E Ratio (TTM) | -1.27 | N/A |
| Interest Coverage (TTM) | -4.99 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -2.08 | N/A |
| Shares Outstanding Growth 5YR AVG | 17.77% | N/A |